Spotlight On: Rituxan® (rituximab) / Truxima® (rituximab-abbs) / Ruxience® (rituximab-pvvr) / Riabni™ (rituximab-arrx) - July 2026 JD Supra 7d
Celltrion's Truxima becomes 1st interchangeable rituximab biosimilar in US Korea Biomedical Review 01:33 Wed, 01 Jul Truxima Genentech Teva All sources
Celltrion draws bullish broker outlooks after second straight sales beat Korea Biomedical Review 02:27 Wed, 08 Jul Biotechnology
Samsung, SK lead Chungcheong investment push The Dong-a Ilbo 00:39 Fri, 03 Jul Samsung Top Tech Brands IT
